Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Disorders of Erythrocytes

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The definition of vitality-the perspectives of Dutch older persons.

BMC public health·2025

Same author

Towards optimal use of antithrombotic therapy of people with cancer at the end of life: A research protocol for the development and implementation of the SERENITY shared decision support tool.

Thrombosis research·2023

Same author

Visual impairment as a predictor for deterioration in functioning: the Leiden 85-plus Study.

BMC geriatrics·2022

Same author

Positive health during the COVID-19 pandemic: a survey among community-dwelling older individuals in the Netherlands.

BMC geriatrics·2022

Same author

HPV type-specific distribution among family members and linen in households of cutaneous wart patients.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Same author

The APOP screener and clinical outcomes in older hospitalised internal medicine patients.

The Netherlands journal of medicine·2020

Same journal

A diagnostic tool for self-poisoned patients: Analysis of gastric content and lavage fluids.

The Netherlands journal of medicine·2020

Same journal

Answer to Photoquiz A bone disorder with skin lesions.

The Netherlands journal of medicine·2020

Same journal

A bone disorder with skin lesions.

The Netherlands journal of medicine·2020

Same journal

Answer to Photoquiz A fascinating liver abscess.

The Netherlands journal of medicine·2020

Same journal

A fascinating liver abscess.

The Netherlands journal of medicine·2020

Same journal

Answer to Photoquiz A polyposis syndrome.

The Netherlands journal of medicine·2020

See all related articles

Search research articles

Related Experiment Video

Updated: May 29, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Anaemia in older persons.

W P J den Elzen¹, J Gussekloo

¹Department of Public Health and Primary Care, Leiden University Medical Centre, Leiden, the Netherlands. w.p.j.den_elzen@lumc.nl

The Netherlands Journal of Medicine

|August 27, 2011

Summary

This summary is machine-generated.

Diagnosing and treating anemia in older adults is crucial. Current guidelines may need revision as factors like vitamin B12, ferritin, and erythropoietin levels require further investigation in elderly populations.

Related Experiment Videos

Last Updated: May 29, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Area of Science:

Gerontology
Hematology
Internal Medicine

Background:

Anemia is prevalent in older individuals, linked to adverse outcomes, necessitating accurate diagnosis and treatment.
Existing diagnostic and therapeutic guidelines for anemia may not fully address the complexities in the elderly population.

Purpose of the Study:

To review key factors in diagnostic and therapeutic algorithms for anemia in older adults.
To highlight areas where current understanding and guidelines require revision for the geriatric population.

Main Methods:

Review of prominent factors in anemia diagnosis and treatment for older individuals.
Analysis of evidence regarding vitamin B12, ferritin, and erythropoietin levels in elderly anemia.
Consideration of age-related physiological changes impacting anemia etiology.

Main Results:

Evidence linking subnormal vitamin B12 to anemia in the general older population is limited and inconclusive.
Ferritin measurements are important in older anemic patients, especially with inflammation, despite ferritin's acute-phase properties.
Elevated erythropoietin levels in older adults are linked to increased mortality, necessitating further research.

Conclusions:

Many aspects of anemia etiology in old age remain unresolved.
Current anemia guidelines, based on classic notions, may need revision for the oldest age groups.
Further research is needed on the clinical relevance and therapeutic implications of vitamin B12 and erythropoietin levels in the elderly.